STRS Ohio’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,900
| Closed | -$769K | – | 2119 |
|
|
2022
Q3 | $769K | Buy |
14,900
+1,400
| +10% | +$57.9K | ﹤0.01% | 1064 |
|
|
2022
Q2 | $334K | Sell |
13,500
-3,900
| -22% | -$86K | ﹤0.01% | 1468 |
|
|
2022
Q1 | $436K | Buy |
17,400
+3,900
| +29% | +$110K | ﹤0.01% | 1496 |
|
|
2021
Q4 | $491K | Buy |
13,500
+1,000
| +8% | +$35.1K | ﹤0.01% | 1482 |
|
|
2021
Q3 | $213K | Sell |
12,500
-37,400
| -75% | -$583K | ﹤0.01% | 1752 |
|
|
2021
Q2 | $668K | Buy |
49,900
+42,900
| +613% | +$1.06M | ﹤0.01% | 1462 |
|
|
2021
Q1 | $358K | Sell |
7,000
-8,400
| -55% | -$505K | ﹤0.01% | 1669 |
|
|
2020
Q4 | $953K | Sell |
15,400
-2,100
| -12% | -$120K | ﹤0.01% | 1097 |
|
|
2020
Q3 | $959K | Buy |
17,500
+5,200
| +42% | +$280K | ﹤0.01% | 952 |
|
|
2020
Q2 | $707K | Buy |
12,300
+12,000
| +4,000% | +$653K | ﹤0.01% | 1079 |
|
|
2020
Q1 | $12K | Buy |
+300
| New | +$12.7K | ﹤0.01% | 1933 |
|
|
2019
Q3 | – | Sell |
-59,600
| Closed | -$447K | – | 2184 |
|
|
2019
Q2 | $554K | Buy |
59,600
+3,800
| +7% | +$44K | ﹤0.01% | 1240 |
|
|
2019
Q1 | $775K | Hold |
55,800
| – | – | ﹤0.01% | 944 |
|
|
2018
Q4 | $608K | Buy |
55,800
+3,400
| +6% | +$35.9K | ﹤0.01% | 1059 |
|
|
2018
Q3 | $662K | Sell |
52,400
-7,800
| -13% | -$94K | ﹤0.01% | 1225 |
|
|
2018
Q2 | $792K | Buy |
60,200
+4,700
| +8% | +$56.2K | ﹤0.01% | 1073 |
|
|
2018
Q1 | $754K | Sell |
55,500
-30,500
| -35% | -$315K | ﹤0.01% | 1060 |
|
|
2017
Q4 | $511K | Hold |
86,000
| – | – | ﹤0.01% | 1316 |
|
|
2017
Q3 | $638K | Buy |
86,000
+10,500
| +14% | +$87.3K | ﹤0.01% | 1252 |
|
|
2017
Q2 | $706K | Buy |
75,500
+22,900
| +44% | +$168K | ﹤0.01% | 1085 |
|
|
2017
Q1 | $382K | Buy |
52,600
+8,400
| +19% | +$60.5K | ﹤0.01% | 1406 |
|
|
2016
Q4 | $327K | Buy |
+44,200
| New | +$318K | ﹤0.01% | 1457 |
|
Other funds holding CCXI
STRS Ohio's CCXI Position: Q4 2022 in Review
STRS Ohio sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 14,900 shares — an estimated $769K sold.
STRS Ohio first reported a position in CCXI in Q4 2016 and held it in 22 quarters. The position peaked at $959K in Q3 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- STRS Ohio reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- STRS Ohio sold 14,900 ChemoCentryx, Inc. shares in Q4 2022, an estimated $769K.
- STRS Ohio first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 22 quarters.
- STRS Ohio's ChemoCentryx, Inc. position peaked at $959K in Q3 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.